On Wednesday, pharmaceutical firm Merck & Co., Inc. (MRK) announced that it is reassessing its first quarter earnings per share estimates, accounting for the Venezuelan government’s planned devaluation of its currency.
The New Jersey-based company said it now sees first quarter EPS coming in a range between 76 cents and 78 cents. Wall Street analysts expect MRK to post an EPS of 86 cents.
Merck will take a one-time, after tax loss of about 5 cents per share in the first quarter because of the impact devaluation will have on the local balance sheet. Moreover, the company expects the devaluation impact to be 2 cents per share spread over the full year of 2013.
Merck shares were down slightly during morning trading on Wednesday. The stock is up about +8.5% over the past year.
The Bottom Line
Shares of Merck (MRK) have a dividend yield of 4.15% based on Wednesday’s intraday trading price of $41.47 and the company’s annualized dividend payout of $1.72 per share.
Merck & Co., Inc. (MRK) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here